Patent Granted for Human Embryo Manipulation

ACT Gets Unethical Patent for Human Embryo Manipulation | LifeNews.com: The embryonic stem cell and cloning company, Advanced Cell Technology, has been granted a patent for what it calls its “single-blastomere technique” for generating human embryonic stem cell lines. ACT claims that the technique produces embryonic stem cell lines without embryo destruction, but the company’s own published data belie the statement.